SMi Presents the 2nd Annual Conference Exhibitions

The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London.

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenousThese are examples of conventional drug deliveryRecently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patchesLong acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industryHabitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expandNow there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volumeSelf-administrative, connected, and ergonomic devices are the new driveSelf-injectable devices include pen injectors for diabetic patientsThe wealth of expansion available in the field of connected devices is hugeThe regulatory landscape is challenging as it evolves rapidly with the market demand for new devices

The benefits of attending:

Developing on last year’s success, this event assembles an international audience to include regulatory, device design, packaging and formulation professionalsThe devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focusThis event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Regulatory Affairs

URL:

Inquiries: https://go.evvnt.com/342399-2?pid=269

More details